← All stories
Health, Longevity & Biohacking

Miller says cardiovascular risks should shape who takes psychedelic treatments

By Egleze Editorial Desk · Published August 10, 2026 · Third Wave Podcast · Psychedelic Medicine’s Biggest Blind Spots | Richard Louis Miller
Miller says cardiovascular risks should shape who takes psychedelic treatments
Third Wave Podcast
Third Wave Podcast
Psychedelic Medicine’s Biggest Blind Spots | Richard Louis Miller

What was said

""If I have cardiovascular issues, these medicines can raise the heart rate and could raise the blood pressure and could possibly cause attackardia and cause an aphib.""

Miller says patients and clinicians should weigh likely benefits against adverse effects, arguing that standard-dose psychedelic use may not be appropriate for some people with heart conditions. He presents cardiovascular strain as a practical screening issue, suggesting some patients might prefer alternatives if they have known risk factors.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Programme
Third Wave Podcast
Episode
Psychedelic Medicine’s Biggest Blind Spots | Richard Louis Miller
Clip time
7:39
Original source
Watch the source segment →
From this episode
Third Wave Podcast
Third Wave Podcast

Psychedelic Medicine’s Biggest Blind Spots | Richard Louis Miller

August 10, 2026 · 44m · 2 Egleze moments
Read episode summary and key points →

More moments from this episode

Health, Longevity & BiohackingRichard Louis Miller alleges big pharma routinely obscures adverse-effects data→
More stories More from Third Wave Podcast